TINA HATHAWAY: Open Payments
NPI 1023529914 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 37 payments from 11 companies in 2025. Trend: 2023 $1,255 · 2024 $659 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $207 |
| Madrigal Pharmaceuticals | 6 | $167 |
| QOL Medical, LLC | 5 | $141 |
| Ardelyx, Inc. | 4 | $83 |
| Gilead Sciences, Inc. | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: REZDIFFRA, Sucraid, RINVOQ, IBSRELA, CREON, ENTYVIO, MAVYRET, OCALIVA.
Industry payments across GA — which companies pay providers there.
